Historical record - last NADAC effective date: 6/19/2024
Product Information
FEXOFENADINE HCL 180 MG TABLET is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.2752 per EA under NDC 45802084778. Its NADAC has been published 120 times since Mar 23, 2022.
FDA first approved this application on Feb 24, 2020.
The High Outlier badge above means this manufacturer's average price in the fexofenadine hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
180 mg/1
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802084778
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
6/19/2024
Active Ingredients
FEXOFENADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212971FDA Approved
2/24/2020
On Market Since
1/7/2022
Pharmacological Classes
Price Statistics
The NADAC for FEXOFENADINE HCL 180 MG TABLET has been published 120 times since Mar 23, 2022, and over the history we have for it it has declined 4.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2752 per EA |
|---|---|
| All-time high | $0.3030 (Aug 10, 2022) |
| All-time low | $0.2298 (May 22, 2024) |
| Median price | $0.2707 |
| Average price | $0.2696 |
| Largest weekly change | +19.7% (Jun 19, 2024) |
| Weeks tracked | 120 |
| Tracking since | Mar 23, 2022 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+4.2%
5Y
N/A
All
-4.4%
Last surveyed Jul 3, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis Israel Pharmaceuticals Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
fexofenadine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FEXOFENADINE HCL 180 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FEXOFENADINE HCL 180 MG TABLET, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.2752 per EA (NDC 45802084778), effective Jul 3, 2024.
How has the price of FEXOFENADINE HCL 180 MG TABLET changed over time?
Over the history we have for it, the NADAC for FEXOFENADINE HCL 180 MG TABLET has declined 4.4%. It has been tracked across 120 weekly CMS publications since Mar 23, 2022.
What are the highest and lowest recorded NADAC prices for FEXOFENADINE HCL 180 MG TABLET?
Since Mar 23, 2022, the NADAC for FEXOFENADINE HCL 180 MG TABLET has ranged from a low of $0.2298 (May 22, 2024) to a high of $0.3030 (Aug 10, 2022), with a median of $0.2707 per EA.
Are there cheaper alternatives to FEXOFENADINE HCL 180 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ALLERGY RELIEF 180 MG TABLET, is $0.2302 per EA — about 16% below FEXOFENADINE HCL 180 MG TABLET.
Who manufactures FEXOFENADINE HCL 180 MG TABLET?
FEXOFENADINE HCL 180 MG TABLET (NDC 45802084778) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.